News

Baidyanath ayurved introduces ‘MedoharGuggulu’

Our Bureau, New Delhi

The Jhansi based Baidyanath, the century old trusted leader in Ayurvedic know how and largest producer of Ayurveda products with portfolio of 700 formulations has introduced ‘MedoharGuggulu’,

Alcon introduces Dailies Total1 water gradient contact lenses

Our Bureau, Mumbai

Alcon, a global leader in eye care and a division of Novartis, has launched Dailies Total1 water gradient contact lenses in India. The daily disposable contact lenses offer exceptional comfort lasting from the beginning

Sun Pharma launches anti-fungal powder Abzorb as prescription & OTC product

Our Bureau, Mumbai

Sun Pharma Consumer Healthcare (CHC), a division of Sun Pharmaceutical Industries has entered into the anti-fungal powder OTC category with launch of Abzorb.

Hikma Pharmaceuticals launches palonosetron hydrochloride injection

London

Hikma Pharmaceuticals Plc (Hikma) announced that its wholly owned US subsidiary West-Ward Pharmaceuticals Corp. (West-Ward), has launched Palonosetron Hydrochloride (HCl) injection, 0.25mg/2mL.

Hetero launches generic FDC combo of ‘emtricitabine & tenofovir alafenamide’ in India

Our Bureau, Mumbai

Hetero, one of India’s leading generic pharmaceutical companies and world’s largest producer of anti-retroviral drugs, announced the launch of the first generic fixed-dose combination (FDC) of ‘emtricitabine (200mg)

Singapore based Haw Par Corporation unveils Tiger Balm Neck and Shoulder Rub for Indian consumers

Our Bureau, Mumbai

Aimed at Indian consumers suffering from tech and posture related neck and shoulder pains due to busy but sedentary lifestyles in India, Tiger Balm Neck and Shoulder Rub was officially launched in Mumbai today after its successful experience

Lupin forays into OTC segment with Softovac

Our Bureau, Mumbai

Pharma major Lupin Limited has made a foray into the over-the-counter (OTC) segment under the ‘Lupin Life Consumer Healthcare’ umbrella with the pan-India launch of Softovac.

Mylan launches FDC of darunavir, ritonavir for HIV-1 treatment-experienced patients

Our Bureau, Mumbai

Mylan Pharmaceuticals Private Limited, a leading global pharmaceutical company, launched Durart R 450, a fixed-dose combination (FDC) drug comprising of Darunavir/Ritonavir 400/50mg for treatment in experienced adults and adolescents weighing more than 40kg with HIV-1 in India.

Glenmark introduces nicotine replacement therapy, Kwitz in India

Our Bureau, Mumbai

Glenmark Pharmaceuticals Limited, a Rs. 9,100 crore research-led global integrated pharmaceutical company, has launched Kwitz, a medically approved nicotine replacement therapy that helps smokers embark on a step by step journey towards a smoke-free life.

Lumenis launches M22 OPT technology for dry & itchy eyes

Our Bureau, Mumbai

With an increasingly use of gadgets like mobiles phones, laptops and computers workaholic people are more prone to dry eye syndrome. Studies show that humans generally blink about 22 times a minute. But

Back

Enquiry Form